Össur Supports Arthritis Research
Announcement from Össur hf.
Reykjavik, 9 September 2011
ÖSSUR SUPPORTS ARTHRITIS RESEARCH UK
- New Experimental Osteoarthritis Treatment Centre
to Lead Exploration of New Therapeutic Options -
Össur hf. and Arthritis Research UK announced today that Össur will be providing research funding to support the establishment of a new experimental osteoarthritis treatment centre (EOTC) in the UK.
Osteoarthritis is the most common form of joint disease, causing pain and stiffness in joints and affecting over 8 million people in the UK. To address this important area of research, Arthritis Research UK is establishing the Össur-supported EOTC, which will test novel treatment and rehabilitation approaches for osteoarthritis. The Centre's research is expected to particularly focus on biomechanical solutions, such as knee braces and other advanced technology applications.
"Osteoarthritis is an ever-increasing health issue affecting millions of people worldwide. It is our hope that our collaboration with Arthritis Research UK and the EOTC will yield important research that deepens both our understanding of OA and the best biomechanical solutions for treating this progressive, debilitating condition," said Jon Sigurdsson, Össur's president and CEO.
Professor Alan Silman, medical director, Arthritis Research UK: "We're constantly searching for innovative ways to treat arthritis and this Experimental Osteoarthritis Treatment Centre and others we intend to launch, are a key part of our new research strategy. We are delighted to be announcing this research collaboration with Össur."
Össur press releases by e-mail
If you wish to receive Össur press releases by e-mail please register at the following web-site: http://www.ossur.com/investormailings.
About Össur
Össur (OMX: OSSR) is a global leader in non-invasive orthopaedics that help people live a life without limitations. Its business is focused on improving people's mobility through the delivery of innovative technologies within the fields of braces, supports, prosthetic limbs and compression therapies. A recognized "Technology Pioneer", Össur invests significantly in research and product development; its award-winning designs ensuring a consistently strong position in the market. Successful patient and clinical outcomes are further empowered via Össur's educational programs and business solutions. Headquartered in Iceland, Össur has major operations in the Americas, Europe and Asia, with additional distributors worldwide. Forward-Looking Statements
This press release includes "forward-looking statements" which involve risks and uncertainties that could cause actual results to differ materially from results expressed or implied by these statements. Össur hf. undertakes no obligation and does not intend to update these forward-looking statements to reflect events or circumstances occurring after this press release. You are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date of this press release. All forward-looking statements are qualified in their entirety by this cautionary statement. About Arthritis Research UK
Arthritis Research UK is the leading authority on arthritis in the UK, conducting scientific and medical research into all types of arthritis and musculoskeletal conditions. Arthritis Research UK is the only charity solely committed to funding high quality research into the cause, treatment and cure of arthritis and is entirely supported by voluntary contributions and legacies. Arthritis Research UK has launched a new range of patient information booklets and leaflets, to provide an ongoing source of information and support to patients suffering from osteoarthritis. For further information visit: www.arthritisresearchuk.org |
